Navigation Links
Novel Molecular Assay for Patient Screening Detects S. aureus and Newly Emerging MRSA Strains Available in the United States
Date:12/3/2013

SIs due to MRSA increase hospital length of stay for patients by an average of 23 days and cost more than $40,000 per case to treat.iii Nasal carriage of S. aureus, including MRSA, is a well-defined risk factor for subsequent infection in surgical patients. Rapid screening and targeted decolonization decreases SSIs by nearly 60 percent and improves clinical and economic outcomes for surgical patients.iv,v

With many commercial assays, SA strains carrying SCCmec where the mecA gene is absent (commonly called "dropout mutants") may be incorrectly detected as MRSA. These false positive results can lead to inappropriate use of vancomycin for surgical prophylaxis and unnecessary, expensive isolation of patients.vi  MRSA strains with the recently discovered mecC gene account for nearly three percent of all new MRSA casesvii but cannot be detected by assays that do not detect that gene.viii These false negative results can lead to inappropriate surgical prophylaxis in patients who should receive vancomycin to cover for MRSA and lack of appropriate isolation precautions to prevent transmission in the operating room and during hospitalization.

The BD MAX StaphSR Assay represents an important milestone in BD's commitment to provide healthcare institutions with cutting edge assays to detect and prevent HAIs. Other HAI assays available on the BD MAX System include BD MAX™ MRSA for the detection of MRSA DNA and BD MAX™ Cdiff for the detection of toxigenic Clostridium difficile DNA. These BD MAX™ HAI Solutions combine efficiency with the flexibility to perform multiple HAI assays in the same run, allowing hospital laboratories to customize testing in response to current and future challenges in the fight against HAIs.

About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument sy
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
3. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
4. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
5. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
8. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
9. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
10. OICR funds Fluorinov Pharma Inc. to further develop its novel drug for the treatment of blood cancers
11. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 ... at 4,396.20, down 0.52%, the Dow Jones Industrial Average finished ... closed at 1,964.68, down 0.41%. The losses were broad based ... negative. The S&P 500 Health Care Sector Index ended the ... 2.75% in the last one month. Investor-Edge has initiated coverage ...
(Date:7/11/2014)... ALBANY, New York , July 11, 2014 /PRNewswire/ ... published by Transparency Market Research "Endoscopy Devices Market (Endoscopes, ... Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019" the ... billion in 2012 and is expected to grow at ... reach an estimated value of USD 36.9 billion in ...
(Date:7/11/2014)... , July 11, 2014 Research ... addition of the "Immunoprotein Diagnostic Testing Market ... the highest CAGR of 6% and is expected ... report to their offering. ... immunoprotein diagnostic testing has been segmented according to ...
Breaking Medicine Technology:Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2
... 2011 "Mammography saves lives – period."  That,s how ... co-Medical Director of Breast Imaging at Edward Hospital, sums up ... The study, which lasted 29 years, showed the use ... least 30%, an even greater extent than previously believed. ...
... Tenn., July 1, 2011 Dr. Ming Wang of ... the first surgeon in the world to perform a ... perform a 3D cataract surgery. The first such ground-breaking ... Center on May 27, 2011 and June 2, 2011, ...
Cached Medicine Technology:Edward Breast Imaging Expert Lauds Swedish Mammography Study 2The World's First 3D LASIK AND Tennessee's First 3D Cataract Surgery Performed 2
(Date:7/11/2014)... 11, 2014 Timex, the leader in ... of the Timex Performance Network, the brand’s new online ... athlete testimonials, seasonal news and special product offers for ... on the legacy of the Timex IRONMAN watch brand ... and endurance athletes nationwide. The hub will reflect the ...
(Date:7/11/2014)... 11, 2014 (HealthDay News) -- Polio is history in ... like Afghanistan, Nigeria and Pakistan. Giving vaccinated children an ... immunity and help eradicate the highly infectious disease, a ... highly effective, immunity wanes as early as a year ... infected and contribute to the spread of the disease, ...
(Date:7/11/2014)... is now providing worldwide clients with the most fashionable ... comes to buying summer wedding dresses online, ladies become ... of beautiful wedding gowns. Recently, the company has launched ... , The company’s current promotion is specially launched ... newest fashion trends. The top experts from AngelWeddingDress want ...
(Date:7/11/2014)... Phoenix, AZ (PRWEB) July 11, 2014 ... an upcoming episode of Innovations with Ed Begley Jr, ... and show times TBA. , In this episode, Innovations ... dose of 100mg docusate sodium in polyethylene glycol base ... learn about how the formulation functions as a hyperosmotic ...
(Date:7/11/2014)... Seattle, WA (PRWEB) July 11, 2014 ... times a year, but the type of material used ... you stay in the game, say researchers presenting their ... Orthopaedic Society of Sports Medicine ( AOSSM ). ... young athletic population, allografts (tissue harvested from a donor) ...
Breaking Medicine News(10 mins):Health News:Timex Announces Launch of Timex Performance Network 2Health News:Researchers Assess New Way to Boost Polio Immunity 2Health News:AngelWeddingDress Will Continuously Unveil More Summer Wedding Dresses for Loyal Clients 2Health News:Alliance Labs & DocuSol® to be Featured in Upcoming Episode of Innovations 2Health News:ACL Reconstructions May Last Longer With Autografts 2
... recent study has traced the loss of functions in ... in through mild cognitive impairment, executive ability// is the ... by researchers at the Mayo Clinic. The results of ... in Madrid confirmed that, after cognitive function starts to ...
... today quashed the admissions given to 23 students in a ... the current academic year. // ,"The division bench ... today held that the college administration had not conducted the ... non-exploitative manner," said advocate Paresh Upadhaya, who argued the case ...
... of the youths working in BPO firms working continuously ... ,The experts explained that working continually on night shifts ... youth. Dr Lim Li Ling, Deputy Director, a specialist ... "Heavy food during night, skipping breakfast, eating lunch in ...
... has stated that it's never too late for a person ... disease.// ,The researchers particularly taking into consideration the ... explained that the exercise need not be of any strenuous ... the difference. Dr Dietrich Rothenbacher, an epidemiologist at the University ...
... hospitals spend for meals for their patients. An area-wise ... times the amounts spent by others.// ,The report ... on patients' meals per week as compared to the ... newspaper, there are huge variations reported. "Highland spending just ...
... Mental health providers can be successfully located with ... Wake Forest University Baptist Medical Center and the ... ,Writing in the journal Clinical Pediatrics, the ... diagnosis and treatment of mental health disorders in ...
Cached Medicine News:Health News:Exercise Activities Helps To Avoid Heart Ailment 2Health News:Mental Health Providers Can Be Successfully Located With Pediatricians 2
... the Prostate Specific Antigen (total PSA) test, has ... manage patients with prostate cancer. Of the different ... was the first approved for the detection of ... rectal examination (DRE) in men aged 50 years ...
Stereo Smile II also includes a blank card and tests,at 60, 120, 240 and 480 sec of arc., ,Smile Test II Includes:, 1 demonstration card, 1 pair pediatric 3-D viewers, 1 pair infant 3-D v...
... Smile Tests at 480 and 120 sec ... children of 6,months to 5 years of ... Smile Tests screen for:, Amblyopia, Strabismus, Significant ... Includes:, 1 demonstration card, 1 pair pediatric ...
... Test and Evaluate Random Dot ... (2500 to 1200 sec of arc) ... Includes:, Graded Circle Test (800 to ... Test for Children (400 to 100 ...
Medicine Products: